EPISODE · Sep 19, 2024 · 9 MIN
EP10 - Basic Research Powers the First Medication for Postpartum Depression
from Women and Mental Health · host Andrew MacQuoid
Postpartum depression (PPD) affects many new mothers, often due to a drop in the neurosteroid allopregnanolone after childbirth. Decades of NIMH-supported research led to the development of brexanolone, the first drug approved to treat PPD. Brexanolone mimics the effects of allopregnanolone, offering fast and effective relief from PPD symptoms, representing a major breakthrough in mental health treatment.
NOW PLAYING
EP10 - Basic Research Powers the First Medication for Postpartum Depression
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m